|
It's time to make your move — toward a future of 20-, 30-, even 50-fold gains in the technologies that will change our world...
With The Emerging Capital Report, you have the opportunity to get in on tomorrow's Microsofts, GEs, Dells and Mercks. They’re tiny right now. They're selling for almost nothing, and they are poised to increase hundreds, if not thousands, of percentage points in the coming months and years.
But it's not as easy as it sounds. That’s where brilliant tech analyst Jonathan Kolber comes in…
Unlike those in the mainstream investment media — who will tell you about mainstream industry trends — Jonathan factors in three cardinal elements into his winning picks: a soundly capitalized business plan; inspired management; and marketable, defensible innovation.
These are the things savvy venture capitalists look for. And using the information in this FREE Special Report, you'll be able to capitalize on the kinds of opportunities that only millionaire venture capitalists typically get to see.
There's one other group of people that discovers once-in-a-lifetime plays early enough to turn just a few grand into $50,000, $100,000, even a million bucks or more...Readers of The Emerging Capital Report newsletter. And you’re invited to join them.
Every one of the stocks you'll read about in this bulletin is a pick readers could have already made 110%, 209%, even 1,052% or more on. But the mind-boggling truth is that these plays and others haven't even begun to really pick up steam yet!
Jonathan will be the first to tell you: The really spectacular technology money typically comes in over time — five, seven or 10 years out...
But that doesn't mean shorter-term gains aren't possible. In fact, Jonathan's entire portfolio of recommendations for readers of The Emerging Capital Report has averaged over 45% growth over the last three years...
Nearly DOUBLE the S&P 500's 26.1% growth rate over the same time period.
Among these are some pretty impressive gains, including:
- 1,249% in 16 months
- 72% in just over 1 year
- 245.32% in 18 months
- 54.93% in just 4½ months.
These are just a few of the literally dozens of profitable tech picks The Emerging Capital Report has revealed to readers in just the last few years.
Yet as spectacular as this track record of is, Jonathan believes the stocks he’s currently following could set new profit benchmarks — starting almost immediately.
According to Jonathan, there's easily another 1,000% or more in possible profits to be made for those who buy in now. Find out all the details in the FREE Special Report that you get with your subscription: “Google" Made Flesh: 30–50 Times Your Money on Tomorrow's Stem Cell Front-Runner
That’s why you shouldn’t wait to join him. And if you act now, you can subscribe to The Emerging Capital Report at our very best offer.
When you subscribe, you’ll receive:
- 12 issues of The Emerging Capital Report, with at least one new emerging technology stock pick every month that has the potential to yield returns that would rival a venture capitalist's
- Special Report #1: "Google" Made Flesh: 30–50 Times Your Money on Tomorrow's Stem Cell Front-Runner. This is the report I've been telling you about — in which Jonathan reveals the company that's almost literally performing miracles. Its primary drug-testing product will be a must-have for any pharma company hoping to avoid another Vioxx-style nightmare... and that's just the start of its amazing profit potential. Best of all, its stem cells are controversy-free... meaning there aren't any political stumbling blocks between it and success. It truly is the "Google" of biotechs — offering a chance for 3,000-5,000% gains!
- Special Report #2: The One Stock That Could Propel Your Portfolio to 100-Fold Profits, in which you'll discover all the details of what'll surely prove to be the most incredible short-term profit opportunity you've ever seen — one that would make even the greediest VC draw in a sharp breath. It's a small U.S. tech firm that's got one of the giants of the hybrid car industry backed into a corner in an ironclad patent infringement lawsuit. Fast-movers could realistically make 2,000% gains almost overnight in an all-but-certain out-of-court settlement, and more than 100 times their money over time.
- Special Report #3: The Technology Stock of the Decade: 50-fold Gains as This Firm Solves Some of the World's Biggest Problems, in which you'll discover the pioneering nuclear science firm helmed by a Kremlin-groomed Russian Cold War defector. Learn how its solutions to security, power and new-economy sanitation could give you back 50 times your money or more. If any one of this company's three major technology solutions soars (the U.S. government has already committed millions), even minor shareholders could reap the profit whirlwind...
- Special Report #4: The Nordic Miracle Worker: Make 50 Times Your Money as This Company Unlocks the Secrets of Life, in which you'll learn all about the Icelandic company that could give you back 50 times your money — but I'm betting on at least 1,000% even in a worst-case scenario. Remember, if any one of this firm's trifecta of advancements takes off, even a minimal investment should multiply dozens of times over...
- Weekly e-mail alerts, giving you FREE analysis of the emerging technology markets, plus buy and sell recommendations you won't find anywhere else
- Access to our members-only Web site, offering you a complete archive of The Emerging Capital Report newsletters and e-mail alerts, plus an up-to-date track record of our stock recommendations.
Once again, you'll get all of this for just $850. And with our “Auto-Renew” program, we'll simply bill your credit card every year until you tell us to stop. You'll never have to worry about the price rising, receiving any pesky renewal notices or ever missing an issue again...
Please act now and take advantage of OUR BEST OFFER.
And you’ll join many very happy readers:
“I want to thank you very much for all the good investment recommendations you have supplied me in the past. As a result, I think I have made some good stock buys.” — Charles W.
|
